-
Ibrexafungerp Against Fluconazole-Resistant Candida auris
2026-09-14
Wiederhold and colleagues evaluated ibrexafungerp against fluconazole-resistant Candida auris using broth microdilution and a delayed-treatment neutropenic mouse model. The study is important because it links consistent in vitro activity with improved survival and reduced kidney fungal burden despite delayed therapy, while also showing that fluconazole was ineffective against the resistant challenge isolate.
-
Ertugliflozin, Brain Insulin Signaling, and Tau
2026-09-14
This study tested whether the SGLT2 inhibitor ertugliflozin could alleviate cognitive and biochemical abnormalities in a rat model of brain insulin signaling disruption. Its central contribution is linking treatment to reduced hippocampal tau hyperphosphorylation, improved IRS-1/Akt/GSK3β signaling, and protection of cholinergic, mitochondrial, apoptotic, and synaptic endpoints.
-
PD98059 MEK Inhibitor: Workflow & Troubleshooting
2026-09-13
PD98059 is a selective, reversible MEK inhibitor for separating ERK1/2-dependent signaling from parallel MAPK responses. This practical guide covers leukemia differentiation and apoptosis workflows, cell proliferation assays, and the evidence boundaries for neuroprotection in ischemia models.
-
Standardized Amplex Red Assay for Autotaxin Inhibitors
2026-09-12
Stylianaki and colleagues describe a fluorometric, microplate-based assay that couples autotaxin activity to Amplex Red oxidation and resorufin fluorescence. The protocol supports primary screening, IC50 determination, false-positive exclusion, and kinetic characterization of autotaxin inhibitors in a scalable in vitro format.
-
Caspase-3/7 Inhibitor I: Workflow Guide
2026-09-12
Use Caspase-3/7 Inhibitor I as a reversible, cell-permeable perturbation tool to distinguish executioner-caspase activity from upstream stress signaling. This workflow adapts phase-specific Candida krusei findings to practical apoptosis assays in mammary epithelial, Jurkat, chondrocyte, and cancer research models.
-
Pitavastatin (NK-104): In Vitro Workflow Guide
2026-09-11
Pitavastatin (NK-104, SKU B1124) provides a defined HMG-CoA reductase inhibitor for cholesterol-biosynthesis assays and related cardiovascular or atherosclerosis research workflows. This dossier supports in vitro and biochemical use; it does not establish clinical treatment, animal dosing, or directly matched paper evidence for a specific experimental outcome.
-
Heparin sodium in Nanovesicle Uptake Research
2026-09-11
Heparin sodium is more than a standard glycosaminoglycan anticoagulant: it can provide a controlled perturbation tool for studying heparan sulfate proteoglycan-dependent nanovesicle uptake. This article connects anti-factor Xa and aPTT benchmarking with exploratory Sertoli-cell and plant nanovesicle workflows while separating established evidence from proposed assay extensions.
-
Brassinolide: From Plant Signal to Translational Tool
2026-09-10
Brassinolide, also encountered in search and catalog contexts as 24-Epibrassinolide, is more than a plant growth regulator. Its activity across plant bioassays, PC-3 apoptosis models, and diabetic rat studies makes it a useful translational probe—provided researchers respect assay-specific biology, chemical identity, and the limits of preclinical evidence.
-
Vancomycin hydrochloride in resistance research
2026-09-10
Vancomycin hydrochloride provides a mechanistically defined Gram-positive benchmark for susceptibility testing, resistance assays, and therapeutic screening. This guide combines practical formulation advice with time-course and PKPD-inspired strategies for separating true resistance from adaptive changes.
-
Amplex Red for H2O2 and Redox Assays
2026-09-09
Amplex Red converts otherwise difficult-to-measure hydrogen peroxide formation into a sensitive fluorescent readout for enzyme, cell, and environmental workflows. This guide shows how to use it for reactive oxygen species detection while adapting the iron-gate findings from mangrove soil research without confusing H2O2 signals with direct measurements of iron or carbon cycling.
-
Fluconazole Workflows for Fungal Resistance Research
2026-09-09
Build more reproducible antifungal susceptibility, resistance, and infection-model experiments with Fluconazole. This guide connects mechanism-led assay design with solvent handling, resistant-isolate controls, and translational interpretation.
-
EdU Cell Proliferation Kit for RA S-Phase Studies
2026-09-08
Translate ARL4C-associated transcriptional signals into a direct DNA-synthesis readout with a non-radioactive TMB workflow. This EdU Cell Proliferation Kit supports RA fibroblast-like synoviocyte studies, perturbation screening, genotoxicity testing assay development, and pharmacodynamic drug evaluation.
-
Light-Inducible RNA Release for Gene Therapy Control
2026-09-07
This 2026 Trends in Biotechnology study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic gene expression at the level of translation. The platform enabled reversible, light-dependent regulation in obesity and retinal disease models, highlighting a potential safety and timing advantage for gene therapies.
-
Placental Exosomal miR-519d-3p in Preeclampsia
2026-09-07
This 2025 study links placenta-derived exosomal miR-519d-3p with altered T-cell behavior relevant to preeclampsia. Using next-generation sequencing and an HTR-8/SVneo–Jurkat model, the authors report increased T-cell proliferation, reduced apoptosis, and a shift toward Th17-associated immune imbalance.
-
Tetrandrine Workflows for Ion Channel Research
2026-09-05
Tetrandrine supports controlled calcium-channel, inflammation, and cell-response experiments when solvent exposure, timing, and orthogonal readouts are planned together. This practical guide converts its DMSO-based formulation into reproducible workflows for ion channel modulation studies, neuroscience research, and cancer biology research while clearly separating established product facts from hypothesis-generating applications.